Deep Tech Startups

BattGenie develops software for battery management systems, using physics-based battery models to optimize charging, state-of-charge and state-of-health estimation for lithium-ion and next-generation batteries. It works with hardware vendors, OEMs, and battery manufacturers to improve energy storage efficiency and safety.

2 investors

Baya Systems builds software-defined fabric technology and interconnect IP for connecting compute, memory, and accelerator components across chiplet-based architectures. It serves semiconductor teams designing AI accelerators, data centers, automotive platforms, and high-performance computing systems.

2 investors

Beemaps provides real-world video and imagery data for physical AI applications, with coverage refreshed on a scale of days. It operates a platform where distributed devices ("Bees") help expand geographic imagery coverage.

2 investors

beeOLED develops blue OLED emitters based on rare-earth (lanthanide) metal complexes, such as cerium or europium, stabilized with organic ligands and made vacuum-vaporizable for OLED display manufacturing. It sells these emitter materials to OLED display and panel manufacturers, and operates its own synthesis laboratory and material pilot plant.

2 investors

BEIT provides physics-based computational approaches for drug discovery, embedding scientists with expertise in physics, mathematics, and engineering into pharmaceutical research programs.

2 investors

Belfort develops purpose-built hardware and algorithmic improvements to accelerate Fully Homomorphic Encryption, allowing sensitive data to be processed without decryption. It targets high-stakes domains including national security and government, finance, healthcare and genomics, and crypto/blockchain.

2 investors

BenchFlow is a data lab that builds stateful environments — with services, files, tools, verifiers, traces, and replay — for training and evaluating AI agents on real computer workflows rather than static prompts. It ships SkillsBench for procedural skills, ClawsBench for simulated workplaces, and the BenchFlow runtime, working with frontier model labs and academic partners.

2 investors

Beyond Limits (BeyondAI) builds hybrid AI that combines machine learning with symbolic reasoning to deliver explainable, human-like decision-making for industrial and complex environments. Its cognitive AI is applied to optimize production, reduce operational costs, improve asset management, and enable predictive maintenance.

2 investors

Bifrost Electronics develops miniaturized cryogenic hardware, including quantum-limited amplifiers, to help pack more qubits into a dilution refrigerator and scale quantum computers. It serves quantum computing researchers and physicists building QPUs.

2 investors

Big Sur Ventures is an early-stage venture capital firm that has invested since 2012 in technology startups from pre-seed through Series A. It backs companies in internet/software ("Power of Internet") and deep tech areas such as quantum, AI, materials, photonics, microelectronics, and nanotechnology.

2 investors

Bigthinx AI builds AI foundation models combining computer vision, generative AI, 3D, digital humans, and spatial computing for the retail and fashion industry. Its products include Lyflike, a generative-AI creative and 3D visualization platform, and Lyfsize, which predicts body measurements and clothing sizes from photos to reduce returns and enable fit recommendations.

2 investors

Bioherent develops label-free biosensors using integrated silicon photonics, surface chemistry, and nanomaterials for in vitro diagnostics, with its AllerWAVE tabletop analyzer and disposable cartridges detecting antibiotic allergies and anaphylaxis for hospitals and labs. It also sells custom silica nanoparticles (NanoKit) for biomedical research and licenses OEM photonic biosensor modules for third-party diagnostic and monitoring platforms.

2 investors

BioHeuris develops non-GMO herbicide tolerance traits for crops such as soybean, sorghum, cotton, and rice, using precision breeding and mutagenomic platforms to help crops resist weeds while reducing herbicide use. It works with seed and chemical companies to bring these traits to market through products like SURON, StrigOUT, and Raizor.

2 investors

BiomeBank develops microbiome-based therapies aimed at restoring the gut microbial ecosystem, with a focus on conditions such as inflammatory bowel disease and Clostridioides difficile infection. The company operates a cGMP manufacturing facility in Adelaide and works with academic and hospital research partners on drug discovery and clinical development.

2 investors

biomodal develops a multi-modal genomic sequencing platform, including its 6-base sequencing and duet evoC products, that profiles epigenetic (5mC, 5hmC), genetic, and fragmentomics biomarkers from a single DNA sample. Its technology is applied to liquid biopsy workflows for applications such as cancer detection.

2 investors

BioScout provides autonomous, solar-powered air sampling devices that detect and identify airborne fungal spores, combining live spore counts with weather data to give growers, agronomists, and agrochemical distributors disease-risk intelligence for fungicide spray timing. Its system uses patented sensor technology and light microscopy to map crop disease risk and reduce unnecessary fungicide applications.

2 investors

BioSqueeze develops well integrity solutions for the oil and gas industry, using biomineralization technology to seal cement gaps and leaks in wells. The company offers multiple sealing products (MicroSeal, MacroSeal, NanoSeal) and diagnostic services for well remediation and decommissioning.

2 investors

Biotheryx is a clinical-stage biopharmaceutical company developing first-in-class targeted protein degraders, including molecular glues and bifunctional degraders, with an initial focus on cancer and inflammatory disease. Its drug discovery work is built on modulating Cereblon and its proprietary PRODEGY platform.

2 investors

biotx.ai maps how genes causally shape human biology by systematically testing every human gene across tissues using large-scale Mendelian randomization, colocalization, and causal AI. This generates high-confidence causal links between genes, diseases, and biomarkers for drug target discovery.

2 investors

BioVersys is a Swiss pharmaceutical company developing small-molecule drugs with novel modes of action to treat drug-resistant bacterial infections, addressing antimicrobial resistance (AMR). Its pipeline targets serious hospital infections such as A. baumannii, S. aureus, and NTM infections.

2 investors

BIRD INITIATIVE supports large corporations in creating new businesses, offering end-to-end new-business development including carve-out exit strategies through its Carve out Studio, and building AI solutions such as real-time factory/warehouse simulators, drone and autonomous-vehicle mobility management, and causal-analysis AI for marketing and HR. It also helps enterprises and research institutions commercialize dormant patents and develop patent strategies.

2 investors

Bitfury operates in the cryptocurrency/blockchain industry, with noted expertise in mining solutions and related technology infrastructure.

2 investors

bitHuman turns photos into real-time, lip-synced video avatars and AI characters with voice, running fully on-device across hardware from Raspberry Pi to iPhone to NVIDIA GPUs. It offers Python and Swift SDKs, a REST API, and a no-code dashboard for developers building talking avatars, illustrated multimedia books, and privacy-sensitive, self-hosted or air-gapped deployments.

2 investors

Bitrobius Genetics is developing Gentrafix, a plasmid-based technology that delivers DNA into human cells and spreads it to adjacent cells to replace mutated genes. The company is building gene therapies for genetic diseases, including mitochondrial gene disorders that currently lack treatments.

2 investors